PT-141 (Bremelanotide) is an FDA- approved synthetic peptide that acts as a melanocortin receptor agonist specifically targeting MC3R and MC4R receptors in the central nervous svstem. Unlike traditional ED nedications that work through vascular mechanisms. PT-141 directlv influences sexual arousal pathwavs in the brain makina it effective for both male and female sexual dvsfunction.
Key Benefits
DA-approved route with predictable absorption, works within 45 minutes, effective for both male and female sexual dysfunction
Mechanism of Actior
Activates melanocortin receptors MC3R/MC4R) in the central nervous system, triggering sexual arousa pathways independent of vascular mechanisms
Hypoactive Sexual Desire Disorder (HSDD) FDA-approved for premenopausal women with acquired, generalized HSDD
Erectile Dysfunction
Effective in men including those unresponsive to PDE5 inhibitors
Female Sexual Arousal Disorder Improves physiological and subjective arousal measures
Reduced Sexual Distress
Clinical trials show sianificant reduction in distress related to low sexual desire
Enhanced Sexual Satisfaction
Improvements in overall sexual satisfactior scores in both partners
Psychological Well-being
Positive effects on relationship satisfaction and quality of life